Navigation Links
Ganeden Biotech Introduces the First Probiotic Thin Strip
Date:9/15/2009

CLEVELAND, Sept. 15 /PRNewswire/ -- Ganeden Biotech Inc., makers of the patented probiotic strain GanedenBC30(R), today announced the launch of the first quick dissolving, thin strip probiotic product. The new thin strip product is the latest in a number of innovative probiotic-enhanced products introduced by Ganeden Biotech over the past year.

The recent popularity of thin strips as a supplement delivery system led Ganeden Biotech to develop the new thin strip product as another option for consumers looking to improve their digestive and immune health with "good bacteria" or probiotics. The thin strip quickly adheres to the tongue making it an ideal delivery system for children, the elderly, individuals with trouble swallowing, and even some pets. In addition to the convenience of the thin strips, they provide an alternative for individuals who are unable or prefer not to take supplements in pill or liquid forms.

Available in a variety of flavors and dosages that have been formulated in applications for adults, children and companion animals, the new thin strips are shelf stable and deliver significant probiotic doses (up to 1.5 billion CFU/strip). The strips are available in convenient, turn-key 10 and 30 pack boxes of individually, foil packed strips that can be produced under private label for rapid market introduction.

Prior to the development of the Ganeden Biotech thin strip product, probiotic thin strip applications were limited as the harsh manufacturing conditions required to develop the strips would render most probiotic strains ineffective. However, the ability of GandenBC30 to survive these conditions, largely due to a naturally-occurring hardened shell of organic material that protects the bacteria, made it a viable probiotic for thin strip applications.

"We are thrilled to introduce this thin strip technology to the probiotic market," said Ganeden Biotech CEO Andrew Lefkowitz. "This innovative application is another step forward in expanding the breadth of convenient probiotic products available to consumers. We look forward to continuing to develop and bring to market new probiotic products that are core to Ganeden Biotech's mission to improve quality of life."

More information about the new thin strips and private label opportunities can be found at www.ganedenlabs.com.

About Ganeden Biotech

Founded in 1996, Ganeden Biotech Inc. is a private company based in Cleveland, Ohio, and is the largest seller of over-the-counter probiotics in the U.S. through its Digestive Advantage and Sustenex brands. It also licenses its patented probiotic bacteria, GanedenBC30, for use in commercial food and beverage applications as well as in medical foods and dietary supplements. GanedenBC30 was found to be Generally Recognized As Safe (GRAS) by an independent expert panel assembled to assess its safety in use as a food ingredient. Digestive Advantage and Sustenex are available at over 40,000 retailers nationwide including Walmart, CVS/pharmacy, Walgreens, Rite-Aid, Stop & Shop, Giant, Publix, Kroger, and Target. For more information, visit www.digestiveadvantage.com, www.sustenex.com, or www.ganedenlabs.com.


'/>"/>
SOURCE Ganeden Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
2. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
3. Isabellas Healthy Bakery Unveils Activate - A New Probiotic Muffin Fortified with GanedenBC30 Probiotic
4. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
5. Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener
6. Ganeden Biotech, Liquid Health Labs Unveil New Drink Technology
7. Ganeden Biotech Introduces GanPro(TM) Direct-Fed Microbial for Livestock
8. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
11. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc announced today ... demand KbioBox developed a sophisticated “3 click” gene dditing off target analysis program ... new website, https://www.kbiobox.com/ and powered by the company’s proprietary BioEngine. ...
(Date:12/8/2016)... ... 08, 2016 , ... This CAST literature review and report looks at problems ... on the economic effects in countries that are major global commodity exporters and importers, ... resultant risk of low level presence (LLP) puts large volumes of trade worth billions ...
(Date:12/8/2016)... Fla. , Dec. 8, 2016  HedgePath ... company that discovers, develops and plans to commercialize ... its shares of common stock were approved for ... will begin trading on the OTCQX, effective today, ... qualify for the OTCQX market, companies must meet ...
(Date:12/8/2016)... 2016  Partnering to fuel Philadelphia,s ... of Southeastern Pennsylvania (" Ben ... of Independence Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... a $6 million funding initiative over a four year ... Responding to a burgeoning economic vitality in digital health, ...
Breaking Biology Technology:
(Date:11/24/2016)... , Nov. 23, 2016 Cercacor today introduced ... and their trainers non-invasively measure hemoglobin, Oxygen ... Rate, and Respiration Rate in approximately 30 seconds. Smaller ... easy and immediate access to key data about their ... a training regimen. Hemoglobin carries oxygen ...
(Date:11/19/2016)... -- Securus Technologies, a leading provider of civil and ... and monitoring, announced today that it has offered a ... independent technology judge determine who has the largest and ... calling platform, and the best customer service. ... what we do – which clearly is not the ...
(Date:11/15/2016)... Nov. 15, 2016  Synthetic Biologics, Inc. (NYSE ... focused on the gut microbiome, today announced the ... shares of its common stock and warrants to ... a price to the public of $1.00 per ... Biologics from the offering, excluding the proceeds, if ...
Breaking Biology News(10 mins):